Ovid Therapeutics Inc. (OVID)
0.33
0.01 (1.54%)
At close: Apr 24, 2025, 12:39 PM
13F Institute Ownership
Total Institutes of 83 in Ovid Therapeutics expanded their positions with an increase of 6 investors compared to the previous quarter. An additional 1.24M shares, as total invested capital declined by $10.27M with ownership percentage increasing from 65.27% to 67.02%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.083
0.08
Call Flow 2,400
92%
Put Flow 200
8%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 10.61% | 7.53M | +0.00% | 7.01M | 26.40% |
| Rubric Capital Management LP | 7.49% | 5.32M | +0.00% | 4.96M | 0.06% |
| Blackrock, Inc. | 5.54% | 3.93M | -8.94% | 3.67M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.